
Weight-loss drug manufacturer Eli Lilly has taken aim at the government, claiming that the UK is “probably the worst country in Europe” for medicine pricing.
Dave Ricks, chief executive of the firm that makes Mounjaro, told the Financial Times that the UK pays less than other nations for its products, and added: “Unless that changes, I don’t think they will see many new medicines and I don’t think they will see much investment.”